1 month ago
General Hospital alum Chris McKenna just revealed he needs emergency jaw surgery this week.
The former Jack recently shared a health update on X, posting an X-ray of his jaw and writing, "I had a broken crown fixed last month and they discovered a spot on my x-ray."
He continued, explaining what this means for his mouth: "Turns out I need emergency surgery in the morning to remove a cyst that has eaten away at my jawbone and have a bone graft. Good thing I broke that tooth! This is gonna hurt but lucky we caught it."
While this certainly isn't something McKenna wanted to hear, the former soap star is making the best of the scary situation. Shortly after his announcement, he posted, "The good news is I'm gonna be on pain meds for weeks and my tweets might be hilarious."
Photo: Disney/Christine Bartolucci
#former #hospital #jack
The former Jack recently shared a health update on X, posting an X-ray of his jaw and writing, "I had a broken crown fixed last month and they discovered a spot on my x-ray."
He continued, explaining what this means for his mouth: "Turns out I need emergency surgery in the morning to remove a cyst that has eaten away at my jawbone and have a bone graft. Good thing I broke that tooth! This is gonna hurt but lucky we caught it."
While this certainly isn't something McKenna wanted to hear, the former soap star is making the best of the scary situation. Shortly after his announcement, he posted, "The good news is I'm gonna be on pain meds for weeks and my tweets might be hilarious."
Photo: Disney/Christine Bartolucci
#former #hospital #jack
2 months ago
DataMEDS AI (MEDS) announced on Sept. 15 that it acquired Helomics and a lab services business, sparking a huge rally in MEDS stock. Shares of MEDS stock gained 87% on Sept. 15 and 275% in the following session. Like the lab services unit, Helomics was sold by Axe Compute (AGPU) and utilizes artificial intelligence (AI) for cancer diagnostics and treatment.
Generally, I'm a big fan of using AI in medicine, and a fan of the companies that do so. In fact, I own two stocks — Schrodinger (SDGR) and Radnet (RDNT) — that specialize in this area; Schrodinger uses AI to help speed up the drug-discovery process, while many of Radnet's diagnostic medical devices utilize AI.
Elon Musk, Who Became the World's First Trillionaire, Still Sleeps in a Tiny $50,000 House Where His Mom Uses the Garage — 'It's Kinda Awesome Though'
How to Play AMZN Stock as Amazon Unveils Project Mercury
JPMorgan Gives Up Forecasting Iran War Endgame as Trump Tells Reporters 'Anything Could Happen With Me'
#meds #shares
Generally, I'm a big fan of using AI in medicine, and a fan of the companies that do so. In fact, I own two stocks — Schrodinger (SDGR) and Radnet (RDNT) — that specialize in this area; Schrodinger uses AI to help speed up the drug-discovery process, while many of Radnet's diagnostic medical devices utilize AI.
Elon Musk, Who Became the World's First Trillionaire, Still Sleeps in a Tiny $50,000 House Where His Mom Uses the Garage — 'It's Kinda Awesome Though'
How to Play AMZN Stock as Amazon Unveils Project Mercury
JPMorgan Gives Up Forecasting Iran War Endgame as Trump Tells Reporters 'Anything Could Happen With Me'
#meds #shares
3 months ago
Zabit Magomedsharipov has another grappling match lined up – this time against top-ranked UFC featherweight Youssef Zalal in the main event of ACBJJ 22 in Istanbul, Turkey, on Aug. 30.
ACBJJ also officially announced Monday that former UFC welterweight champion Belal Muhammad will compete on the card, taking on former Oktagon ****** leholder Kerim Engizek.
Magomedsharipov vs. Zalal will be contested at 154 pounds, while Muhammad grapples Engizek in a 198-pound match.
Magomedsharipov was expected to face Raul Rosas Jr. in a grappling contest this past July, his first appearance since retiring from the UFC in 2020, but withdrew from the card with an undisclosed injury,
Zalal re-enters competition after losing to Aljamain Sterling in a UFC main event this past April, snapping a nine-fight unbeaten streak inside the octagon with five of those wins coming by way of submission.
#match
ACBJJ also officially announced Monday that former UFC welterweight champion Belal Muhammad will compete on the card, taking on former Oktagon ****** leholder Kerim Engizek.
Magomedsharipov vs. Zalal will be contested at 154 pounds, while Muhammad grapples Engizek in a 198-pound match.
Magomedsharipov was expected to face Raul Rosas Jr. in a grappling contest this past July, his first appearance since retiring from the UFC in 2020, but withdrew from the card with an undisclosed injury,
Zalal re-enters competition after losing to Aljamain Sterling in a UFC main event this past April, snapping a nine-fight unbeaten streak inside the octagon with five of those wins coming by way of submission.
#match
3 months ago
Nicole "Snooki" Polizzi is giving fans a look at her preparations for her upcoming hysterectomy amid her battle with cervical cancer.
The Jersey Shore: Family Vacation star, 38, took to TikTok on Tuesday, July 28, to share the must-have items she's purchased in preparation for her surgery.
The products for the procedure, which Polizzi said is happening "soon," include several fan-recommended buys, like an abdominal band to support her midsection, constipation aids and a weighted heating pad.
In another video, Polizzi shared that she also purchased a few loose-fitting nightgowns, as well as oversized underwear to keep the area around her incision comfortable.
"You guys know I don't like pain, and I want to be cozy and comfy, and I needed recommendations on how to, like, recover the best way after my hysterectomy," Polizzii said. "If I'm missing anything, mamas, anybody who has gotten a hysterectomy with the big cut, please help. I don't want to feel pain. If you know me, I'm a baby. I don't like pain. I don't like any type of uncomfortableness, and yeah, I just, I don't like it. So obviously, I'll have, like, some pain meds and stuff."
#don 't #polizzi #purchased
The Jersey Shore: Family Vacation star, 38, took to TikTok on Tuesday, July 28, to share the must-have items she's purchased in preparation for her surgery.
The products for the procedure, which Polizzi said is happening "soon," include several fan-recommended buys, like an abdominal band to support her midsection, constipation aids and a weighted heating pad.
In another video, Polizzi shared that she also purchased a few loose-fitting nightgowns, as well as oversized underwear to keep the area around her incision comfortable.
"You guys know I don't like pain, and I want to be cozy and comfy, and I needed recommendations on how to, like, recover the best way after my hysterectomy," Polizzii said. "If I'm missing anything, mamas, anybody who has gotten a hysterectomy with the big cut, please help. I don't want to feel pain. If you know me, I'm a baby. I don't like pain. I don't like any type of uncomfortableness, and yeah, I just, I don't like it. So obviously, I'll have, like, some pain meds and stuff."
#don 't #polizzi #purchased
3 months ago
Image: Ben Duffy/Sherdog.com illustration
We at Sherdog provide regular, in-depth preview coverage for allmajor events, including our oft-praised preview column along withour "Sheehan Show" handling all sorts of related matters includingbetting. With those official sources for picks handled, we wouldlike to take the edge off here and get a bit lighter with ourbreakdowns.
The industry of sports betting is exploding before our very eyes,with billions of dollars pumping in since legalization stateside.Oftentimes, those driving the lines are right on the money withtheir openings, valuations and ****** yses. Occasionally they are wayoff, or otherwise merit some additional conversation. That is wherewe come in with this reinvigorated series of Prime Picks, where,stealing a line from game show host Sam Reich, we hold hands andjump into the abyss together for Saturday morning's Ultimate Fighting Championship's jaunt toAbu Dhabi. Try it out.
MagomedAnkalaev (-575)
MagomedZaynukov (-290)
MagomedTuchalov (-900)
We admit, we're getting away with a technicality here by notincluding MuhammadSaid in our same-name parlay. After all, Magomed is the Russiantransliteration of Muhammad. Also, good luck trying to search thename "Muhammad Said" without any additional qualifiers and stillgarner any information about the fighter of that namesake. All ofthese Magomeds are rightful favorites, and in the case of two ofthe more expected victors of Tuchalov and Ankalaev, moneyline betsare just not worth it.
Therefore, we pair these three gents together, all of whom haveclear paths to victory against foes who have displayed exploitableweaknesses. Some are giving BogdanGuskov a proverbial "puncher's chance" to win this fight,although he might have some surprise jiu-jitsu in his back pocket.Nevertheless, unless Ankalaev chooses to take things horizontal—heis not nearly as keen on doing this despite his reputation, onlydoing so in his first triumphant meeting against AlexPereira. Against "Poatan," he did attempt a clean dozen shots.While he did not land a single one, the mere threat of the takedownallowed him to get in on the stoic striker and do some work. A fewfaked shots against "Hitman," whose takedown defense has alreadycome into question despite his recent successes, would payimmediate dividends.
We get to the meat of the order. More specifically, the pork. JohnPork. "Wild Chanco" Zaynukov, who actually had his nickname onFight Finder as "John Pork" until specifically reaching out torequest that it be taken down. RobertWhittaker didn't have the same problem when Ben Fowlkes andChad Dundas first crowned him "Bobby Knuckles" in the always-great"Co-Main Event Podcast" and it stuck. Even though DamianRzepecki will hold a slight bit more experience and morestoppages on his ledger, he and Zaynukov stand at differentterraces in their respective careers.
To get signed through the promotion, the Dagestan native in thepipeline of the Abdulmanap Nurmagomedov School
We at Sherdog provide regular, in-depth preview coverage for allmajor events, including our oft-praised preview column along withour "Sheehan Show" handling all sorts of related matters includingbetting. With those official sources for picks handled, we wouldlike to take the edge off here and get a bit lighter with ourbreakdowns.
The industry of sports betting is exploding before our very eyes,with billions of dollars pumping in since legalization stateside.Oftentimes, those driving the lines are right on the money withtheir openings, valuations and ****** yses. Occasionally they are wayoff, or otherwise merit some additional conversation. That is wherewe come in with this reinvigorated series of Prime Picks, where,stealing a line from game show host Sam Reich, we hold hands andjump into the abyss together for Saturday morning's Ultimate Fighting Championship's jaunt toAbu Dhabi. Try it out.
MagomedAnkalaev (-575)
MagomedZaynukov (-290)
MagomedTuchalov (-900)
We admit, we're getting away with a technicality here by notincluding MuhammadSaid in our same-name parlay. After all, Magomed is the Russiantransliteration of Muhammad. Also, good luck trying to search thename "Muhammad Said" without any additional qualifiers and stillgarner any information about the fighter of that namesake. All ofthese Magomeds are rightful favorites, and in the case of two ofthe more expected victors of Tuchalov and Ankalaev, moneyline betsare just not worth it.
Therefore, we pair these three gents together, all of whom haveclear paths to victory against foes who have displayed exploitableweaknesses. Some are giving BogdanGuskov a proverbial "puncher's chance" to win this fight,although he might have some surprise jiu-jitsu in his back pocket.Nevertheless, unless Ankalaev chooses to take things horizontal—heis not nearly as keen on doing this despite his reputation, onlydoing so in his first triumphant meeting against AlexPereira. Against "Poatan," he did attempt a clean dozen shots.While he did not land a single one, the mere threat of the takedownallowed him to get in on the stoic striker and do some work. A fewfaked shots against "Hitman," whose takedown defense has alreadycome into question despite his recent successes, would payimmediate dividends.
We get to the meat of the order. More specifically, the pork. JohnPork. "Wild Chanco" Zaynukov, who actually had his nickname onFight Finder as "John Pork" until specifically reaching out torequest that it be taken down. RobertWhittaker didn't have the same problem when Ben Fowlkes andChad Dundas first crowned him "Bobby Knuckles" in the always-great"Co-Main Event Podcast" and it stuck. Even though DamianRzepecki will hold a slight bit more experience and morestoppages on his ledger, he and Zaynukov stand at differentterraces in their respective careers.
To get signed through the promotion, the Dagestan native in thepipeline of the Abdulmanap Nurmagomedov School
4 months ago
Boston Scientific Corporation (NYSE:BSX) is one of the best low volatility stocks to buy under $50. BofA cut the price target on Boston Scientific Corporation (NYSE:BSX) to $61 from $68 on June 12 and maintained a Buy rating on the shares. It noted that the firm's services team continues to highlight a lower utilization environment, and Barclays wants to take a more conservative view on 2027 medtech company estimates, given valuations are already reflecting utilization risk. It further told investors that the firm is lowering 2027 estimates across its larger-cap coverage where there's exposure to utilization and inflation.
Boston Scientific Corporation (NYSE:BSX) also received a rating update from Canaccord on June 1. The firm lowered the price target on the stock to $70 from $71, reiterating a Buy rating on the shares. Canaccord stated that it updated its model on the stock to take into account slowdowns in the U.S. Watchman business in 2026 and 2027, which have negative implications on its revenue and EPS estimates.
Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation.
While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
Boston Scientific Corporation (NYSE:BSX) also received a rating update from Canaccord on June 1. The firm lowered the price target on the stock to $70 from $71, reiterating a Buy rating on the shares. Canaccord stated that it updated its model on the stock to take into account slowdowns in the U.S. Watchman business in 2026 and 2027, which have negative implications on its revenue and EPS estimates.
Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation.
While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
4 months ago
Stryker Corporation (NYSE:SYK) is one of the 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.On June 2, Stryker Corporation (NYSE:SYK) announced the launch of TPX HD. It is a small bone power tool designed for demanding orthopaedic procedures, including total joint revisions, minimally invasive surgery, and oral maxillofacial procedures.Mike Carlin, president of Stryker's Ortho Tech division, said revision surgeries are among the most demanding procedures, particularly when cutting metal. He noted that TPX HD was built for situations where "visibility is limited, precision matters, and surgeons need a tool they can trust to perform."The firm stated TPX HD has several features. It includes a tapered attachment to build on visibility in confined ****** es, a housing that helps reduce motor heat exposure at high operating speeds, and a shorter handpiece with an improved grip to improve ergonomics.
The company also said TPX HD delivers up to 296% more torque and operates up to 40% faster than its TPX Micro Drill at high speed. It also provides customizable controls through its CORE 2 Console and multiple specialized attachments.Stryker Corporation (NYSE:SYK) is a medical technology company that offers products and services that help improve patient and healthcare outcomes. It works under the MedSurg and Neurotechnology, Orthopaedics, and Spine segments.While we acknowledge the potential of SYK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.Disclosure: None. Follow Insider Monkey on Google News.
The company also said TPX HD delivers up to 296% more torque and operates up to 40% faster than its TPX Micro Drill at high speed. It also provides customizable controls through its CORE 2 Console and multiple specialized attachments.Stryker Corporation (NYSE:SYK) is a medical technology company that offers products and services that help improve patient and healthcare outcomes. It works under the MedSurg and Neurotechnology, Orthopaedics, and Spine segments.While we acknowledge the potential of SYK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.Disclosure: None. Follow Insider Monkey on Google News.
4 months ago
Professional Fighters League (PFL) is set to stage PFL San Diego later TONIGHT (Sat., June 27, 2026) inside Pechanga Arena in San Diego, California. Headlining the event will be a Featherweight fight between A.J. McKee Jr. and undefeated rising star, Salamat Isbulaev, who sits at a perfect 10-0, 1-0 PFL.
In further action, former Ultimate Fighting Championship (UFC) stars Liz Carmouche and Viviane Araujo will collide in a women’s Flyweight action in the co-headliner, while Alfie Davis and Alexander Shabliy will provide fireworks in a thrilling Lightweight bout on the main card.
Many readers check in before, during and after the fights to share their thoughts on all of the action, as the main card kicks off at 8 p.m. ET on the ESPN App and ESPN2. Feel free to leave a comment (or several) about the bouts and chat with all the other Maniacs during the show — it’s always a lot of fun!
145 lbs.: A.J. McKee Jr. vs. Salamat Isbulaev
125 lbs.: Liz Carmouche vs. Viviane Araujo
155 lbs.: Alfie Davis vs. Alexander Shabliy
205 lbs.: Abraham Bably vs. Rob Wilkinson
145 lbs.: Khasan Magomedsharipov vs. Joshua Weems
125 lbs.: Ariane Lipski da Silva vs. Jena Bishop
155 lbs.: Gamid Khizriev vs. Lorenzo Parente
135 lbs.: Justin Wetzell vs. Sarvarjon Khamidov – Khamidov defeats Wetzell via third-round submission (rear-naked choke)
125 lbs.: Shannon Clark vs. Ilara Joanne – Clark defeats Joanna via third-round TKO
135 lbs.: Cobey Fehr vs. Daniel Bzdigian – Fehr defeats Bzdigian via first-round submission
Coming soon…
In further action, former Ultimate Fighting Championship (UFC) stars Liz Carmouche and Viviane Araujo will collide in a women’s Flyweight action in the co-headliner, while Alfie Davis and Alexander Shabliy will provide fireworks in a thrilling Lightweight bout on the main card.
Many readers check in before, during and after the fights to share their thoughts on all of the action, as the main card kicks off at 8 p.m. ET on the ESPN App and ESPN2. Feel free to leave a comment (or several) about the bouts and chat with all the other Maniacs during the show — it’s always a lot of fun!
145 lbs.: A.J. McKee Jr. vs. Salamat Isbulaev
125 lbs.: Liz Carmouche vs. Viviane Araujo
155 lbs.: Alfie Davis vs. Alexander Shabliy
205 lbs.: Abraham Bably vs. Rob Wilkinson
145 lbs.: Khasan Magomedsharipov vs. Joshua Weems
125 lbs.: Ariane Lipski da Silva vs. Jena Bishop
155 lbs.: Gamid Khizriev vs. Lorenzo Parente
135 lbs.: Justin Wetzell vs. Sarvarjon Khamidov – Khamidov defeats Wetzell via third-round submission (rear-naked choke)
125 lbs.: Shannon Clark vs. Ilara Joanne – Clark defeats Joanna via third-round TKO
135 lbs.: Cobey Fehr vs. Daniel Bzdigian – Fehr defeats Bzdigian via first-round submission
Coming soon…
4 months ago
A.J. McKee (145.6) vs. Salamat Isbulaev (145.8) Liz Carmouche (126) vs. Viviane Araujo (125.8) Alfie Davis (156) vs. Alexandr Shabliy (155.9) Abraham Bably (205.6) vs. Rob Wilkinson (205.8) Khasan Magomedsharipov (145.8) vs. Joshua Weems (146) Ariane Lipski da Silva (126) vs. Jena Bishop (125) Sarvarjon Khamidov (137.6: Missed Weight) vs. Justin Wetzell (135.6) Shannon Clark (125.4) vs. Ilara Joanne (124.8) Cobey Fehr (135.8) vs. Daniel Bzdigian (135.6) Sherdog's live PFL San Diego coverage will begin Saturday at 8 p.m. ET.
Top notch featherweights headline PFL San Diego: Tune in Saturday, June 27 at 8 p.m. ET on ESPN 2.
Sherdog Scores Jay Pettry scores the round:
Mike Pendleton scores the round:
Tristen Critchfield scores the round:
Sherdog Scores Jay Pettry scores the round:
Mike Pendleton scores the round:
Tristen Critchfield scores the round:
Sherdog Scores Jay Pettry scores the round:
Mike Pendleton scores the round:
Tristen Critchfield scores the round:
Top notch featherweights headline PFL San Diego: Tune in Saturday, June 27 at 8 p.m. ET on ESPN 2.
Sherdog Scores Jay Pettry scores the round:
Mike Pendleton scores the round:
Tristen Critchfield scores the round:
Sherdog Scores Jay Pettry scores the round:
Mike Pendleton scores the round:
Tristen Critchfield scores the round:
Sherdog Scores Jay Pettry scores the round:
Mike Pendleton scores the round:
Tristen Critchfield scores the round:
4 months ago
Boston Scientific Corporation (NYSE:BSX) is one of the best low volatility stocks to buy under $50. BofA cut the price target on Boston Scientific Corporation (NYSE:BSX) to $61 from $68 on June 12 and maintained a Buy rating on the shares. It noted that the firm's services team continues to highlight a lower utilization environment, and Barclays wants to take a more conservative view on 2027 medtech company estimates, given valuations are already reflecting utilization risk. It further told investors that the firm is lowering 2027 estimates across its larger-cap coverage where there's exposure to utilization and inflation.
Boston Scientific Corporation (NYSE:BSX) also received a rating update from Canaccord on June 1. The firm lowered the price target on the stock to $70 from $71, reiterating a Buy rating on the shares. Canaccord stated that it updated its model on the stock to take into account slowdowns in the U.S. Watchman business in 2026 and 2027, which have negative implications on its revenue and EPS estimates.
Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation.
While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
Boston Scientific Corporation (NYSE:BSX) also received a rating update from Canaccord on June 1. The firm lowered the price target on the stock to $70 from $71, reiterating a Buy rating on the shares. Canaccord stated that it updated its model on the stock to take into account slowdowns in the U.S. Watchman business in 2026 and 2027, which have negative implications on its revenue and EPS estimates.
Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation.
While we acknowledge the potential of BSX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
4 months ago
A.J. McKee (145.6)vs. Salamat Isbulaev (145.8) Liz Carmouche (126)vs. Viviane Araujo (125.8) Alfie Davis (156) vs.Alexandr Shabliy (155.9) Abraham Bably (205.6)vs. Rob Wilkinson (205.8) KhasanMagomedsharipov (145.8) vs. Joshua Weems (146) Ariane Lipski daSilva (126) vs. Jena Bishop (125) SarvarjonKhamidov (137.6: Missed Weight) vs. Justin Wetzell (135.6)Shannon Clark(125.4) vs. Ilara Joanne (124.8) Cobey Fehr (135.8) vs.Daniel Bzdigian (135.6) Sherdog's live PFL San Diego coverage will begin Saturday at 7 p.m. ET.
Top notchfeatherweights headline PFL San Diego: Tune in Saturday, June 27 at7 p.m. ET on ESPN 2.
Sherdog Scores Jay Pettry scores the round:
Tristen Critchfield scores the round:
Mike Pendleton scores the round:
Sherdog Scores Jay Pettry scores the round:
Tristen Critchfield scores the round:
Mike Pendleton scores the round:
Sherdog Scores Jay Pettry scores the round:
Tristen Critchfield scores the round:
Mike Pendleton scores the round:
Top notchfeatherweights headline PFL San Diego: Tune in Saturday, June 27 at7 p.m. ET on ESPN 2.
Sherdog Scores Jay Pettry scores the round:
Tristen Critchfield scores the round:
Mike Pendleton scores the round:
Sherdog Scores Jay Pettry scores the round:
Tristen Critchfield scores the round:
Mike Pendleton scores the round:
Sherdog Scores Jay Pettry scores the round:
Tristen Critchfield scores the round:
Mike Pendleton scores the round:
5 months ago
(NewsNation) — As the use of injectable weight-loss drugs rises, so do the known side effects. While many of the reported issues are physical, there are also reports of a prominent psychological effect.
It's called "ghost fat" or "phantom fat." It refers to patients who have lost a considerable amount of weight but still see themselves as having a larger body. Psychology Today describes it as the same concept as phantom limb syndrome. When someone loses a limb or gets plastic surgery, the mind can't fully comprehend the drastic physical change, and it can sometimes lead to them still feeling that it's there.
The phenomenon isn't just with GLP-1s, but with all dramatic weight loss that happens quickly rather than gradually. According to Medscape, patients who have undergone bariatric surgery also suffer from "ghost fat." Some reported seeing little or no change in their body shape despite substantial weight loss for 18 to 30 months.
Companies turn to telehealth providers to limit GLP-1 drug costs
Plastic surgeon and obesity medicine specialist Dr. Terry Dubrow explained on "Jesse Weber Live" Thursday that the experience can occur regardless of how the weight is lost.
It's called "ghost fat" or "phantom fat." It refers to patients who have lost a considerable amount of weight but still see themselves as having a larger body. Psychology Today describes it as the same concept as phantom limb syndrome. When someone loses a limb or gets plastic surgery, the mind can't fully comprehend the drastic physical change, and it can sometimes lead to them still feeling that it's there.
The phenomenon isn't just with GLP-1s, but with all dramatic weight loss that happens quickly rather than gradually. According to Medscape, patients who have undergone bariatric surgery also suffer from "ghost fat." Some reported seeing little or no change in their body shape despite substantial weight loss for 18 to 30 months.
Companies turn to telehealth providers to limit GLP-1 drug costs
Plastic surgeon and obesity medicine specialist Dr. Terry Dubrow explained on "Jesse Weber Live" Thursday that the experience can occur regardless of how the weight is lost.
1 yr. ago
That is not what I heard on the news.
There are others offering the same package.
MarkJCarney
already knows USA would flip the switch when they are off their meds. USA has always endangered Canadians. Simply put we know how to do business without putting a gun in the fold. Trump
There are others offering the same package.
MarkJCarney
already knows USA would flip the switch when they are off their meds. USA has always endangered Canadians. Simply put we know how to do business without putting a gun in the fold. Trump
